SUMMARY Molecular hybridisation using cloned hepatitis B virus DNA (HBV DNA) was applied to liver and serum samples from 46 children (39 with liver diseases and seven controls) for detection of HBV DNA sequences, free and integrated into the liver cell genome. HBV DNA integration was observed in 10 children. The young age of some of these cases indicates that such integration can occur early in liver disease and is not related to the duration of viral infection. Thirteen children exhibited serological evidence of active viral multiplication. All but one had free HBV DNA in liver tissue and integrated HBV DNA sequences were found in four cases. Integrated HBV DNA sequences alone were also detected in three children with neither HBV-antigens nor HBV DNA in serum. One had inactive cirrhosis, and the two others, chronic active hepatitis. Consequently DNA hybridisation may be useful for diagnosis, in the absence of serological signs of HBV infection; its specificity was enhanced in the present investigation by negative results in six children with autoimmune chronic active hepatitis. Taken together, the above results imply that HBV-DNA 
Molecular hybridisation using a labelled nucleic acid as probe allows detection of complementary DNA or RNA sequences.
In liver disease, cloned HBV DNA provides such a probe for detecting HBV DNA sequences and for determining the state of viral DNA in the host cellthat is, free or integrated into the host genome. The presence of HBV DNA sequences integrated into the cellular DNA was first shown in (1) The methods used for molecular hybridisation in serum and liver have already been described. 1 5 9 Briefly, after extraction, liver DNA was digested by Hind III, a restriction endonuclease which cuts cellular DNA at a specific nucleotide sequence but does not cut the HBV DNA so far studied.'0 The DNA fragments resulting from digestion were separated according to their size by agarose gel electrophoresis and transferred to a nitrocellulose filter according to the Southern technique." Serum DNA was similarly treated but the digestion step was omitted. Cloned HBV DNA12 was labelled by nick-translation13 to a specific activity of 3X 108 to 4X 108 cpm/,ug. Hybridisation was carried out with this probe after denaturation. When previously studied samples displayed Hind III restriction liver DNA patterns, they were of one of three types:5 9 (1) the first was characterised by a band in the 3-2 kilobase pair position -that is, the cloned HBV DNA position -with a smear below it, this pattern corresponded to free cellular HBV DNA and to intermediate replicative forms of viral DNA, (2) the second was characterised by discrete bands located above the 3X2 kilobase pair position, corresponding to HBV DNA sequences integrated into the liver cell genome, and (3) the third pattern was a combination of the two others and indicated the presence of both free and integrated viral DNA.
The age of our present groups of children presenting with such patterns varied from five months to 15 years and the duration of their disease, from two months to six years.
HBSAG-POSITIVE CHILDREN (GROUP I)
When suitable tissue was available for testing, HBsAg and HBcAg were always detected in the liver of these patients (Fig. 1) .
In patients 1 to 12, the Hind III liver DNA patterns always showed a band in the 3.2 kilobase pair position with, in all patients but one (12), a long smear below this position. In four of these children, additional bands corresponding to high molecular weight DNA fragments were observed. (Representative cases of this pattern are shown in Fig. 2.) Except for patient 12, all these patients also had free viral DNA in the serum, concomitantly with HBeAg. Because of the presence of HBV DNA in the serum of patient 13, the absence of viral DNA in his liver could be considered a false negative result, especially as the amount of DNA extracted was very low (less than 6 ,ug) and as he also had HBsAg and HBeAg in the serum and HBV antigens in the liver.
No hybridisation pattern could be found either in the liver or in the serum of patients 14 and 15, no HBeAg was detected in their serums either.
All the children in group I had chronic hepatitis but no clear cut relationship could be established between hybridisation and histological patterns, especially in the cases of chronic active or chronic persistent hepatitis.
Furthermore, integrated HBV DNA sequences were found in some children with recent HBV infection. Although non A-non B hepatitis cannot be excluded in patients totally seronegative for HBV markers, the HBV DNA integration observed in some cases suggests that their disease may be related to HBV. Thus, HBV DNA hybridisation appears especially important in diagnosis. Its usefulness is enhanced in cases where neither past antigenaemia nor any notion of HBV contagion can be found. Such a condition was evidenced in patient 21, whose familial contagion was detected after the result of the hybridisation test was known, and in patient 22, whose post-transfusion hepatitis had never been serologically related to HBV. Conversely, because of the negative hybridisation results observed in patients with autoimmune hepatitis, it seems unlikely that HBV is concerned in the pathogenesis of this kind of chronic active hepatitis.
Integrated HBV DNA sequences in the Hind III liver DNA pattern has already been found in totally seronegative patients with inactive cirrhosis.5 Our series included one case of inactive cirrhosis, however, and two others of chronic active hepatitis displaying a Hind III pattern. This suggests that integration of HBV DNA alone is not always associated with an inactive liver disease.
The three children who developed fatal hepatic failure also proved of interest in clarifying the time of integration, as the latter obviously occurred less than two or four months after the clear onset of their disease. Furthermore one of them was a five months old child in whom an earlier HBV carrier state can be certainly excluded.
In addition, the HBV serological patterns of these three patients raise the question of the relationship between the immune response and the state of HBV DNA. In general, the severity of liver damage in fulminant cases of hepatitis does not seem to be directly related to the degree of viral multiplication. 16 One explanation suggested for massive hepatocellular necrosis is the destruction of a large number of infected hepatocytes by immune mechanisms. In the connection, the occurrence of an early enhanced humoral antibody response was stressed in contrast with the late outcome of the same humoral pattern during recovery in selflimited acute hepatitis.17-19 Cell-mediated immunity is also a probable factor determining the clinical course of HBV infection.20
Integrated sequences were found in all our three hepatic failure-cases. Free viral DNA and therefore viral multiplication was absent in two of them. It was present in the third child, but in this patient the absence of HBsAg in the liver and of HBV DNA in the serum suggests that viral multiplication was decreasing, and may even have recently stopped.
It thus appears that in these severe cases, the host immune factors are better able to rapidly destroy cells where replication is taking place, than cells containing only HBV DNA sequences integrated into their genome. Whatever the cause of cellular necrosis, the persistence of cells with integrated sequences alone implies that in these cells, either viral multiplication has spontaneously resolved or integration has occurred independently of viral multiplication.
Furthermore, in these three children as well as in patients with chronic hepatitis, the presence of discrete bands in the Hind III integration patterns could be explained by the existence of preterential sites in the host genome for HBV DNA integration.5
The exact role of the remaining integrated HBV DNA sequences and of their integration sites in the outcome of the disease remains to be investigated. The present results indicate that the integration of HBV DNA sequences into the host cellular genome is an early event which might occur as soon as two months after the onset of hepatitis B, and is consequently not related to the duration of viral multiplication.
This study also shows that integrated HBV DNA could be the only remaining marker of HBV infection, even in the presence of an active liver disease. 
